| Product Code: ETC9961468 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) C-Reactive Protein Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) C-Reactive Protein Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) C-Reactive Protein Market - Industry Life Cycle |
3.4 United States (US) C-Reactive Protein Market - Porter's Five Forces |
3.5 United States (US) C-Reactive Protein Market Revenues & Volume Share, By Assay Type, 2021 & 2031F |
3.6 United States (US) C-Reactive Protein Market Revenues & Volume Share, By Detection Range, 2021 & 2031F |
3.7 United States (US) C-Reactive Protein Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 United States (US) C-Reactive Protein Market Revenues & Volume Share, By Analysis Mode, 2021 & 2031F |
3.9 United States (US) C-Reactive Protein Market Revenues & Volume Share, By End- User, 2021 & 2031F |
3.10 United States (US) C-Reactive Protein Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 United States (US) C-Reactive Protein Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases such as cardiovascular diseases and diabetes that necessitate the monitoring of C-reactive protein levels. |
4.2.2 Growing awareness among the population regarding preventive healthcare measures and the importance of early detection of inflammatory conditions. |
4.2.3 Technological advancements in diagnostic techniques leading to more accurate and efficient measurement of C-reactive protein levels. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and commercialization of C-reactive protein tests. |
4.3.2 Limited reimbursement policies for C-reactive protein testing, especially in certain healthcare settings. |
4.3.3 Competition from alternative biomarkers for inflammation and infection diagnostics. |
5 United States (US) C-Reactive Protein Market Trends |
6 United States (US) C-Reactive Protein Market, By Types |
6.1 United States (US) C-Reactive Protein Market, By Assay Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) C-Reactive Protein Market Revenues & Volume, By Assay Type, 2021- 2031F |
6.1.3 United States (US) C-Reactive Protein Market Revenues & Volume, By Immunoturbidimetric Assay, 2021- 2031F |
6.1.4 United States (US) C-Reactive Protein Market Revenues & Volume, By ELISA, 2021- 2031F |
6.1.5 United States (US) C-Reactive Protein Market Revenues & Volume, By Chemiluminescence Immunoassay, 2021- 2031F |
6.1.6 United States (US) C-Reactive Protein Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) C-Reactive Protein Market, By Detection Range |
6.2.1 Overview and Analysis |
6.2.2 United States (US) C-Reactive Protein Market Revenues & Volume, By hs-CRP, 2021- 2031F |
6.2.3 United States (US) C-Reactive Protein Market Revenues & Volume, By Conventional CRP, 2021- 2031F |
6.2.4 United States (US) C-Reactive Protein Market Revenues & Volume, By cCRP, 2021- 2031F |
6.3 United States (US) C-Reactive Protein Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 United States (US) C-Reactive Protein Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.3 United States (US) C-Reactive Protein Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 United States (US) C-Reactive Protein Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.3.5 United States (US) C-Reactive Protein Market Revenues & Volume, By Inflammatory Bowel Disease, 2021- 2031F |
6.3.6 United States (US) C-Reactive Protein Market Revenues & Volume, By Endometriosis, 2021- 2031F |
6.3.7 United States (US) C-Reactive Protein Market Revenues & Volume, By Lupus, 2021- 2031F |
6.3.8 United States (US) C-Reactive Protein Market Revenues & Volume, By Inflammatory Diseases, 2021- 2031F |
6.3.9 United States (US) C-Reactive Protein Market Revenues & Volume, By Inflammatory Diseases, 2021- 2031F |
6.4 United States (US) C-Reactive Protein Market, By Analysis Mode |
6.4.1 Overview and Analysis |
6.4.2 United States (US) C-Reactive Protein Market Revenues & Volume, By Serum, 2021- 2031F |
6.4.3 United States (US) C-Reactive Protein Market Revenues & Volume, By Plasma, 2021- 2031F |
6.4.4 United States (US) C-Reactive Protein Market Revenues & Volume, By Blood, 2021- 2031F |
6.5 United States (US) C-Reactive Protein Market, By End- User |
6.5.1 Overview and Analysis |
6.5.2 United States (US) C-Reactive Protein Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 United States (US) C-Reactive Protein Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 United States (US) C-Reactive Protein Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.5.5 United States (US) C-Reactive Protein Market Revenues & Volume, By Assisted Living Healthcare Facilities, 2021- 2031F |
6.5.6 United States (US) C-Reactive Protein Market Revenues & Volume, By Home, 2021- 2031F |
6.6 United States (US) C-Reactive Protein Market, By Product Type |
6.6.1 Overview and Analysis |
6.6.2 United States (US) C-Reactive Protein Market Revenues & Volume, By Kits, 2021- 2031F |
6.6.3 United States (US) C-Reactive Protein Market Revenues & Volume, By Reagents, 2021- 2031F |
7 United States (US) C-Reactive Protein Market Import-Export Trade Statistics |
7.1 United States (US) C-Reactive Protein Market Export to Major Countries |
7.2 United States (US) C-Reactive Protein Market Imports from Major Countries |
8 United States (US) C-Reactive Protein Market Key Performance Indicators |
8.1 Adoption rate of high-sensitivity C-reactive protein (hs-CRP) testing in clinical practice. |
8.2 Number of research studies published on the utility of C-reactive protein testing in various disease conditions. |
8.3 Investment and funding trends in companies developing novel C-reactive protein testing technologies. |
9 United States (US) C-Reactive Protein Market - Opportunity Assessment |
9.1 United States (US) C-Reactive Protein Market Opportunity Assessment, By Assay Type, 2021 & 2031F |
9.2 United States (US) C-Reactive Protein Market Opportunity Assessment, By Detection Range, 2021 & 2031F |
9.3 United States (US) C-Reactive Protein Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 United States (US) C-Reactive Protein Market Opportunity Assessment, By Analysis Mode, 2021 & 2031F |
9.5 United States (US) C-Reactive Protein Market Opportunity Assessment, By End- User, 2021 & 2031F |
9.6 United States (US) C-Reactive Protein Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10 United States (US) C-Reactive Protein Market - Competitive Landscape |
10.1 United States (US) C-Reactive Protein Market Revenue Share, By Companies, 2024 |
10.2 United States (US) C-Reactive Protein Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here